NYSE, CO - Global Cord Blood Corp
Pantheon was a special purpose acquisition company formed for the purpose of
acquiring, through a stock exchange, asset acquisition or other similar business
combination, an operating business in the People?s Republic of China. Pantheon
China consummated its initial public offering on December 20, 2006 and generated
aggregate gross proceeds of $34,500,000. On June 30, 2009, Pantheon acquired
China Cord Blood Services Corporation ("CCBS") by purchasing 93.94% of its
outstanding shares from existing shareholders in exchange for an aggregate of
54,345,104 newly issued ordinary shares of its corporate successor, China Cord
Blood Corporation (?China Cord Blood?), the surviving company of the
redomestication of Pantheon to the Cayman Islands. ...
Read SEC Filing on NASDAQ.com »